Q2878863 (Q2878863): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
(Created claim: summary (P836): The IGC of the Calouste Gulbenkian Foundation will create the first single cell analysis CVTT in Portugal (Single Cell Hub), a non-existing differentiating service that brings together cutting-edge technology and scientific excellence, in an emerging and critical area for biomedicine. This infrastructure will allow the creation of a collaborative network that strengthens the scientific and business structure, generating new approaches that benef...) |
||||||||||||||
Property / summary | |||||||||||||||
The IGC of the Calouste Gulbenkian Foundation will create the first single cell analysis CVTT in Portugal (Single Cell Hub), a non-existing differentiating service that brings together cutting-edge technology and scientific excellence, in an emerging and critical area for biomedicine. This infrastructure will allow the creation of a collaborative network that strengthens the scientific and business structure, generating new approaches that benefit public health. (English) | |||||||||||||||
Property / summary: The IGC of the Calouste Gulbenkian Foundation will create the first single cell analysis CVTT in Portugal (Single Cell Hub), a non-existing differentiating service that brings together cutting-edge technology and scientific excellence, in an emerging and critical area for biomedicine. This infrastructure will allow the creation of a collaborative network that strengthens the scientific and business structure, generating new approaches that benefit public health. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: The IGC of the Calouste Gulbenkian Foundation will create the first single cell analysis CVTT in Portugal (Single Cell Hub), a non-existing differentiating service that brings together cutting-edge technology and scientific excellence, in an emerging and critical area for biomedicine. This infrastructure will allow the creation of a collaborative network that strengthens the scientific and business structure, generating new approaches that benefit public health. (English) / qualifier | |||||||||||||||
point in time: 7 July 2021
|
Revision as of 10:17, 7 July 2021
Project Q2878863 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q2878863 in Portugal |
Statements
1,010,908.46 Euro
0 references
47.0 percent
0 references
29 March 2017
0 references
31 March 2022
0 references
FUNDAÇÃO CALOUSTE GULBENKIAN
0 references
O IGC da Fundação Calouste Gulbenkian irá criar o primeiro CVTT de Análise de Célula Única em Portugal (Single Cell Hub), um serviço diferenciador não existente, que congrega tecnologia de ponta e excelência científica, numa área emergente e critica para a biomedicina. Esta infraestrutura vai permitir criar uma rede colaborativa que fortalece a estrutura científica e empresarial, gerando novas abordagens que beneficiam a saúde pública. (Portuguese)
0 references
The IGC of the Calouste Gulbenkian Foundation will create the first single cell analysis CVTT in Portugal (Single Cell Hub), a non-existing differentiating service that brings together cutting-edge technology and scientific excellence, in an emerging and critical area for biomedicine. This infrastructure will allow the creation of a collaborative network that strengthens the scientific and business structure, generating new approaches that benefit public health. (English)
7 July 2021
0 references
Oeiras, União das freguesias de Oeiras e São Julião da Barra, Paço de Arcos e Caxias
0 references
Identifiers
LISBOA-01-0246-FEDER-000037
0 references